Prof Richard White
Prof of Infectious Disease Modelling
London School of Hygiene & Tropical Medicine
Keppel St
London
WC1E 7HT
United Kingdom
Richard G White (BSc, MSc, PhD) is Professor of Infectious Disease Modelling in the Centre for the Mathematical Modelling of Infectious Diseases, the TB Centre, and the Vaccine Centre at the London School of Hygiene and Tropical Medicine.
He is Director of the TB Modelling and Analysis Consortium (TB MAC) and co-leads the LSHTM TB Modelling Group with Rein Houben.
Richard was awarded a BSc in Physics from Durham University and an MSc in Medical Demography from LSHTM. He was awarded a PhD in Infectious Disease Modelling in 2006, and led the establishment of the LSHTM’s Centre for the Mathematical Modelling of Infectious Diseases in 2007. He was awarded a Methodology Research Fellowship from the UK Medical Research Council in 2009 and the Director's Award for Outstanding Contribution to Research in 2020. Richard was co-head of the Department of Infectious Disease Epidemiology with Katherine Fielding between 2018-and 2021.
Richard currently serves on LSHTM's Senate and Innovation Committees, is Chair of the LSHTM Global Health Economics Centre Steering Committee and an Advisory Panel member for the LSHTM TB Centre.
Affiliations
Centres
Teaching
Richard teaches on the mathematical modelling of the spread and control of infectious diseases in the UK and internationally.
He organises the LSHTM Infectious Disease Modelling MSc Module and Summer Short Course and with Emilia Vynnycky (Public Health England), Lara Gosce (MSc Module) and Nicky McCreesh (Short Course).
He is co-author of the textbook: An Introduction to Infectious Disease Modelling, published by Oxford University Press.
Research
Richard's research focus is the mathematical and statistical modelling of the transmission and control of infectious diseases, particularly TB and HIV.
He has co-authored around 190 peer-reviewed scientific publications.
He is currently PI or LSHTM PI on around 5 research grants including:
TB Modelling and Analysis Consortium (BMGF), Modelling to estimate the health impact of novel tuberculosis vaccines on TB burden in people living with HIV (NIH), To what extent does protection of BCG vaccination against a PoI endpoint translate into a PoD endpoint? (BMGF), Modeling of TB vaccine investments and impact (BMGF), and Improving scientific and public health decision making by developing technologies to increase use of robust methods to calibrate and analyse complex mathematical models (Wellcome).
He is an Associate Editor for IJTLD and a permanent reviewer for Lancet Respiratory Medicine.
Richard currently supervises PhD students, and welcomes new PhD students, in TB modelling.
Selected Publications
